Detection of donor-derived CMV-specific T cells in cerebrospinal fluid in a case of CMV meningoencephalitis after cord blood stem cell transplantation

スポンサーリンク

概要

• 論文の詳細を見る
• 2013-02-01

著者

• Okada Masaya

  Division Of Hematology And Oncology Department Of Internal Medicine Hyogo College Of Medicine

• TANIGUCHI Kyoko

  Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicin

• Tamaki Hiroya

  Division Of Hematology Department Of Internal Medicine Hyogo College Of Medicine

• Ishii Shinichi

  Division Of Hematology Department Of Medicine Kobe University Graduate School Of Medicine

• Ikegame Kazuhiro

  Division Of Hematology Department Of Internal Medicine Hyogo College Of Medicine

• Yoshihara Satoshi

  Division Of Hematology Department Of Internal Medicine Hyogo College Of Medicine

• Fujioka Tatsuya

  Division Of Hematology Department Of Internal Medicine Hyogo College Of Medicine

• Ogawa Hiroyasu

  Division Of Hematology Department Of Internal Medicine Hyogo College Of Medicine

• Kaida Katsuji

  Division Of Hematology Department Of Internal Medicine Hyogo College Of Medicine

• Inoue Takayuki

  Division Of Hematology Department Of Internal Medicine Hyogo College Of Medicine

• Kato Ruri

  Division Of Hematology Department Of Internal Medicine Hyogo College Of Medicine

• OGAWA Hiroyasu

  Division of Hematology, Department of Internal Medicine, Hyogo Medical College

• SOMA Toshihiro

  Division of Hematology, Department of Internal Medicine, Hyogo Medical College

• TANIGUCHI Kyoko

  Division of Hematology, Department of Internal Medicine, Hyogo Medical College

関連論文

• Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
• 9年後対側に再発した異時性両側精巣悪性リンパ腫の1例
• Extreme eosinophilia caused by interleukin-5-producing disseminated colon cancer
• Interlaboratory Comparison of Quantitative RT-PCR Based Detection for Minimal Residual Disease in Leukemias : A Standardization Approach in Japan
• 同種骨髄移植後のhuman herpes virus-6血症患者に発症したbronchioltis obliterans organizing pneumonia (BOOP)様肺病変
• Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
• 小児および成人造血器悪性腫瘍に対する非血縁さい帯血移植の比較検討
• Successful treatment of relapsed T-cell non-Hodgkin's lymphoma with allogeneic peripheral blood stem cell transplantation with double conditioning
• Different Kinetics of WT1 and PML-RARα Gene Expression Levels during Remission Induction Therapy with All-trans Retinoic Acid Alone in Acute Promyelocytic Leukemia
• Effect of heparin addition on expansion of cord blood hematopoietic progenitor cells in three-dimensional coculture with stromal cells in nonwoven fabrics
• Monitoring Minimal Residual Disease in Leukemia Using Real-time Quantitative Polymerase Chain Reaction for Wilms Tumor Gene (WT1)
• Lethal Adenovirus Infection in a Patient Who Had Undergone Nonmyeloblative Stem Cell Transplantation
• Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
• 同種骨髄移植における GVHD 予防法の検討
• 骨髄移植後の気管支肺胞洗浄液におけるリンパ球CD4/CD8比とサイトメガロウイルス感染との関連性
• 骨髄移植とサイトメガロウイルス感染 : 感染の危険因子
• 非血縁者間骨髄移植におけるCMV感染とpre - emptive therapy
• 骨髄移植患者における気管支肺胞洗浄液を用いたサイトメガロウイルス抗原検索によるCMV感染のモニタリングに関する検討
• Cyclophosphamideとウサギ抗ヒト胸腺細胞免疫グロブリンの前処置にて緊急に骨髄移植を施行した肺炎合併の重症再生不良性貧血
• A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
• Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte homeostasis
• Acquired hemophilia A with sigmoid colon cancer : successful treatment with rituximab followed by sigmoidectomy
• A retrospective analysis of bortezomib therapy for Japanese patients with relapsed or refractory multiple myeloma : β2-microglobulin associated with time to progression
• Dose Modification of Imatinib by Monitoring the Level of BCR-ABL Transcript in Chronic Myelogenous Leukemia
• Increased Expression of Insulin-Like Growth Factor I is Associated with Ara-C Resistance in Leukemia
• Regulatory T cell-like activity of Foxp3^+ adult T cell leukemia cells
• Stanniocalcin-1 as a Novel Marker to Detect Minimal Residual Disease of Human Leukemia
• Imatinib Mesylate in Conjunction with Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Philadelphia Chromosome Positive Leukemias : Report of 4 Cases
• Detection of Clone-Specific Immunoglobulin Heavy Chain Genes in the Bone Marrow of B-cell-Lineage Lymphoma after Treatment
• Separation of antileukemic effects from graft-versus-host disease in MHC-haploidentical murine bone marrow transplantation : participation of host immune cells
• Progressive osteosclerosis and visceral calcification after cord blood transplantation
• Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate (^Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma
• Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
• Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
• Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
• Hyperbaric Oxygen in Addition to Antibiotic Therapy Is Effective for Bisphosphonate-Induced Osteonecrosis of the Jaw in a Patient with Multiple Myeloma
• Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma
• Failure in Detection of Epstein-Barr Virus and Cytomegalovirus in Specimen Obtained by Fine Needle Aspiration Biopsy of Thyroid in Patients with Subacute Thyroiditis
• Population pharmacokinetics of docetaxel in patients with hepatic dysfunction treated in an oncology practice
• Pharmacokinetics and pharmacodynamics of protein-unbound docetaxel in cancer patients
• Treatable Subsets in Cancer of Unknown Primary Origin
• Unmanipulated Reduced-Intensity Stem Cell Transplantation from a Haploidentical Donor Mismatched at 3 HLA Antigens to a Patient with Leukemic Transformation of Myelodysplastic Syndrome : Successful Second Transplantation after Graft Rejection
• Sensitive immunohistochemical detection of WT1 protein in tumors with anti-WT1 antibody against WT1 235 peptide
• High frequencies of less differentiated and more proliferative WT1-specific CD8^+ T Cells in bone marrow in tumor-bearing patients : An important role of bone marrow as a secondary lymphoid organ
• Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
• Induction of Erythroid-Specific Genes by Overexpression of GATA-2 in K562 Cells
• Biased usage of BV gene families of T-cell receptors of WT1 (Wilms' tumor gene)-specific CD8^+ T cells in patients with myeloid malignancies
• P2-163 ラジオアイソトープ標識抗体療法剤ゼヴァリン^[○!R]イットリウムによる血球減少の調査(一般演題 ポスター発表,有害事象・副作用,臨床から学び臨床へと還元する医療薬学)
• Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor
• Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma
• Fludarabine- and Cyclophosphamide-Based Nonmyelobalative Conditioning Regimen for Transplantation of Chronic Granulomatous Disease : Possible Correlation with Prolonged Pure Red Cell Aplasia
• Tocilizumab is effective for pulmonary hypertension associated with multicentric Castleman's disease
• Reduced-Intensity Conditioning Followed by Unrelated Umbilical Cord Blood Transplantation for Advanced Hematologic Malignancies : Rapid Engraftment in Bone Marrow
• Secondary Acute Promyelocytic Leukemia in a Patient With Non-Hodgkin's Lymphoma Treated With VP-16 and MST-16
• The Role of Screening Bronchoalveolar Lavage in BMT Patients
• Changes in Microbial Flora in Neutropenic Patients With Hematological Disorders After the Hanshin-Awaji Earthquake
• High-dose therapy combined with peripheral blood stem cell transplantation for advanced low-grade follicular lymphoma: single-institution experience in Japan
• Myelodysplastic syndrome with B cell clonality in a patient five years after renal transplantation
• Recombinant human erythropoietin for late-onset anemia after allogeneic bone marrow transplantation
• Glutathione S-transferase theta 1 gene (GSTT1) defect in Japanese patients with myelodysplastic syndromes
• Correlation between immunological abnormalities and prognosis in myelodysplastic syndrome patients
• Detection of donor-type alveolar macrophages in transplantation with highly purified CD34^+ bone marrow cells
• Myelodysplastic changes in three cases within 100 days after allogeneic bone marrow transplantation
• Impact of Cytogenetics on Outcome of Stem Cell Transplantation for Acute Myeloid Leukemia in First Remission : A Large-Scale Retrospective Analysis of Data from the Japan Society for Hematopoietic Cell Transplantation
• Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Rescued with a Second Allogeneic Stem Cell Transplantation from a Haploidentical Mother after Relapse following Cord Blood Transplantation
• Relationships between Hematological Recovery and Overall Survival in Older Adults Undergoing Allogeneic Bone Marrow Transplantation
• Forum 第31回日本造血細胞移植学会ランチョンセミナー Ph[+]白血病に対する新規チロシンキナーゼ阻害薬ダサチニブの治療戦略
• Wilms Tumor Gene WT1 Peptide-Based Immunotherapy Induced a Minimal Response in a Patient with Advanced Therapy-Resistant Multiple Myeloma
• WT1_, a Ninemer Peptide Derived from Wilms' Tumor Gene Product, Is a Candidate Peptide for the Vaccination of HLA-A^*0201-Positive Patients with Hematopoietic Malignancies
• Successful Treatment of Tacrolimus (FK506)-Related Leukoencephalopathy with Cerebral Hemorrhage in a Patient Who Underwent Nonmyeloablative Stem Cell Transplantation
• WT1 Peptide-Based Immunotherapy for Patients with Lung Cancer : Report of Two Cases
• Minimal influence of tocilizumab on IFN-γ synthesis by tuberculosis antigens
• Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
• Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
• Hepatosplenic αβ T cell lymphoma
• イマチニブに対して Late Suboptimal Response を示した慢性期CML症例に対する治療選択
• Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
• Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
• Sustained improvement of cardiac function with persistent amyloid deposition in a patient with multiple myeloma-associated cardiac amyloidosis treated with bortezomib
• Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results
• Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
• Identification of a WT1 protein-derived peptide, WT1_, : as a HLA-A^*0206-restricted, WT1-specific CTL epitope
• A WT1 protein-derived, naturally processed 16-mer peptide, WT1_, is a promiscuous helper peptide for induction of WT1-specific Th1-type CD4^+ T cells
• Comparison of Long-Term Clinical Outcomes of CHOP Chemotherapy between Japanese Patients with Nodal Peripheral T-Cell Lymphomas and Those with Diffuse Large B-Cell Lymphoma in the Study Group of the Tohoku Hematology Forum
• Clinicopathological Features of Malignant Lymphoma in Japan : The Miyagi Study
• Tocilizumab, a humanized anti-interleukin-6 receptor antibody, ameliorated clinical symptoms and MRI findings of a patient with ankylosing spondylitis
• Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
• Direct antiglobulin test-negative autoimmune hemolytic anemia associated with HLA-haploidentical stem cell transplantation
• Use of mycophenolate mofetil in patients received allogeneic hematopoietic stem cell transplantation in Japan
• Successful treatment with nilotinib after imatinib failure in a CML patient with a four-way Ph chromosome translocation and point mutations in BCR/ABL gene
• Successful treatment of acquired hemophilia A, complicated by chronic GVHD, with tocilizumab
• Pharmacokinetics-based optimal dose prediction of donor source-dependent response to mycophenolate mofetil in unrelated hematopoietic cell transplantation
• 座談会 濾胞性リンパ腫に対する治療戦略
• 重篤な鼻出血から診断されたアグレッシブNK細胞白血病例
• Strategy for bone marrow transplantation in eculizumab-treated paroxysmal nocturnal hemoglobinuria
• Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
• Feasibility of unmanipulated haploidentical stem cell transplantation using standard GVHD prophylaxis for HLA-homozygous patients
• Spontaneous Regression of Pulmonary Involvement after Smoking Reduction and Removal of and Radiation Therapy for Langerhans Cell Histiocytosis of the Sphenoid Bone: Which Comes First, the Chicken or the Egg?
• Low incidences of acute and chronic graft-versus-host disease after unrelated bone marrow transplantation with low-dose anti-T lymphocyte globulin
• Detection of donor-derived CMV-specific T cells in cerebrospinal fluid in a case of CMV meningoencephalitis after cord blood stem cell transplantation

もっと見る 閉じる

スポンサーリンク